Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Nicholson

Showing results (321-330 of 357) with videos related to

Pageof 36
Sort By:
Journal of Pediatric Surgery|July 15, 2019
Trephination versus wide excision for the treatment of pediatric pilonidal diseaseJames M Prieto, Kyle D Checchi, Karen M Kling, et al.
The Journal of Pathology|July 9, 1999
An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancerM A Gonzalez, S E Pinder, P M Wencyk, et al.
Breast Cancer Research : BCR|March 19, 2013
A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancerJohn F R Robertson, J Michael Dixon, D Mark Sibbering, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Use of reverse transcription-polymerase chain reaction methodology to detect estrogen-regulated gene expression in small breast cancer specimensJ M Knowlden, J M Gee, S Bryant, et al.
International Journal of Cancer|December 1, 1994
Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapyJ M Gee, J F Robertson, I O Ellis, et al.
Cancer Research|August 28, 2001
Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatmentsJ Albanell, J Codony-Servat, F Rojo, et al.
Oncogene|August 1, 1993
Expression and amplification of cyclin genes in human breast cancerM F Buckley, K J Sweeney, J A Hamilton, et al.
Breast Cancer Research and Treatment|January 1, 1996
Effects of short-term antiestrogen treatment of primary breast cancer on estrogen receptor mRNA and protein expression and on estrogen-regulated genesR A McClelland, D L Manning, J M Gee, et al.
Endocrinology|September 10, 2003
The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitroJ M W Gee, M E Harper, I R Hutcheson, et al.
Journal of Medicinal Chemistry|February 3, 2006
New arylthioindoles: potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studiesGabriella De Martino, Michael C Edler, Giuseppe La Regina, et al.
Pageof 36

Showing results (321-330 of 357) with videos related to

Sort By:
Pageof 36
Journal of Pediatric Surgery|July 15, 2019
Trephination versus wide excision for the treatment of pediatric pilonidal diseaseJames M Prieto, Kyle D Checchi, Karen M Kling, et al.
The Journal of Pathology|July 9, 1999
An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancerM A Gonzalez, S E Pinder, P M Wencyk, et al.
Breast Cancer Research : BCR|March 19, 2013
A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancerJohn F R Robertson, J Michael Dixon, D Mark Sibbering, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Use of reverse transcription-polymerase chain reaction methodology to detect estrogen-regulated gene expression in small breast cancer specimensJ M Knowlden, J M Gee, S Bryant, et al.
International Journal of Cancer|December 1, 1994
Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapyJ M Gee, J F Robertson, I O Ellis, et al.
Cancer Research|August 28, 2001
Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatmentsJ Albanell, J Codony-Servat, F Rojo, et al.
Oncogene|August 1, 1993
Expression and amplification of cyclin genes in human breast cancerM F Buckley, K J Sweeney, J A Hamilton, et al.
Breast Cancer Research and Treatment|January 1, 1996
Effects of short-term antiestrogen treatment of primary breast cancer on estrogen receptor mRNA and protein expression and on estrogen-regulated genesR A McClelland, D L Manning, J M Gee, et al.
Endocrinology|September 10, 2003
The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitroJ M W Gee, M E Harper, I R Hutcheson, et al.
Journal of Medicinal Chemistry|February 3, 2006
New arylthioindoles: potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studiesGabriella De Martino, Michael C Edler, Giuseppe La Regina, et al.
Pageof 36